Delivery Order SPE2DB22D3009-SPE2DB25FBB69
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,470.53 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $3,712.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) with an ultimate completion date of August 1, 2025. This non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.16 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-pack units) on July 28, 2025, with completion scheduled for July 29, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $1,673.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on July 25, 2025, with completion targeted for July 28, 2025. This non-set-aside award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on July 24, 2025, with a ceiling value of $1,583.26 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery vehicle with DLA. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $10,222.79. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 30, 2025, supporting federal medical procurement needs. The contract is classified as a child order under a larger indefinite delivery contract vehicle and carries no set-aside designation, indicating open...
- The U.S. Defense Department's Medical Supply Chain awarded a $16,048.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Naloxone 2mg/2mL (10-pack units) on July 28, 2025, with completion targeted for August 22, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Naloxone HCl 4 mg nasal spray. The delivery order has a potential value of $2,039.75 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $938.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4 mg doses of naloxone nasal spray to be delivered to a location in Conshohocken, Pennsylvania between September 7-8, 2023. As a leading distributor of pharmaceuticals and medical supplies, Amerisourcebergen will provide 2 units of the opioid overdose reversal medication to the DLA, the agency that supplies the United States military. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $3,984.02 delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The contractor will perform this delivery order from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBB69Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,301.63 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray (2-pack units) on July 23, 2025, with completion required by July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The contract is not set-aside and reflects competitive procurement of a critical opioid antagonist medication for military and federal healthcare systems. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and is registered in the System for Award Management as a qualified federal medical procurement vendor. This delivery order falls within AmerisourceBergen's broader portfolio of pharmaceutical and medical supply deliveries to the Defense Logistics Agency, which encompasses a wide spectrum of therapeutic domains including specialty medications, generic drugs, vaccines, and medical devices. The company's federal contract awards consistently demonstrate capability to fulfill both small-value transactions and substantial orders through competitively awarded mechanisms. The naloxone supply supports military healthcare readiness and aligns with federal initiatives to maintain opioid antagonist availability across Defense Health Agency, U.S. Coast Guard, and related government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/23/25 |